Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19447868

Clin. Cancer Res. 2009 May 15 15 10 3600-9

Download in:

View as

General Info

PMID
19447868